Assembly Biosciences, Inc.
ASMB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11 | $10 | $9 | $7 |
| % Growth | 12.1% | 2.2% | 28% | – |
| Cost of Goods Sold | $0 | $16 | $0 | $14 |
| Gross Profit | $11 | -$6 | $9 | -$7 |
| % Margin | 100% | -67.5% | 100% | -94.1% |
| R&D Expenses | $17 | $16 | $15 | $14 |
| G&A Expenses | $5 | $5 | $5 | $5 |
| SG&A Expenses | $5 | $5 | $5 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$16 | $0 | -$14 |
| Operating Expenses | $22 | $5 | $19 | $5 |
| Operating Income | -$11 | -$11 | -$10 | -$12 |
| % Margin | -100.9% | -115.2% | -105.5% | -156.7% |
| Other Income/Exp. Net | $2 | $1 | $1 | $1 |
| Pre-Tax Income | -$9 | -$10 | -$9 | -$10 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$10 | -$9 | -$10 |
| % Margin | -85.2% | -105.9% | -93.6% | -140.5% |
| EPS | -1.2 | -1.33 | -1.17 | -1.72 |
| % Growth | 9.8% | -13.7% | 32% | – |
| EPS Diluted | -1.2 | -1.33 | -1.17 | -1.72 |
| Weighted Avg Shares Out | 8 | 8 | 8 | 7 |
| Weighted Avg Shares Out Dil | 8 | 8 | 8 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$9 | -$11 | -$10 | -$12 |
| % Margin | -84.9% | -114.9% | -105.2% | -156.3% |